| Combined inhibition of CDK4/6 and PI3K/AKT/mTOR pathways induces a synergistic anti-tumor effect in malignant pleural mesothelioma cells MA Bonelli, G Digiacomo, C Fumarola, R Alfieri, F Quaini, A Falco, ... Neoplasia 19 (8), 637-648, 2017 | 104 | 2017 |
| Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data V Casadio, D Calistri, M Tebaldi, S Bravaccini, R Gunelli, G Martorana, ... Urologic oncology: seminars and original investigations 31 (8), 1744-1750, 2013 | 101 | 2013 |
| Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer G Tedaldi, M Tebaldi, V Zampiga, R Danesi, V Arcangeli, M Ravegnani, ... Oncotarget 8 (29), 47064, 2017 | 91 | 2017 |
| Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer C Arienti, M Zanoni, S Pignatta, A Del Rio, S Carloni, M Tebaldi, G Tedaldi, ... Oncotarget 7 (14), 18424, 2016 | 56 | 2016 |
| DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach V Casadio, C Molinari, D Calistri, M Tebaldi, R Gunelli, L Serra, F Falcini, ... Journal of Experimental & Clinical Cancer Research 32, 1-9, 2013 | 51 | 2013 |
| Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma M Zanoni, AC Sarti, A Zamagni, M Cortesi, S Pignatta, C Arienti, M Tebaldi, ... Cell Death & Disease 13 (1), 80, 2022 | 31 | 2022 |
| ACE2 and TMPRSS2 potential involvement in genetic susceptibility to SARS-COV-2 in cancer patients S Ravaioli, M Tebaldi, E Fonzi, D Angeli, M Mazza, F Nicolini, A Lucchesi, ... Cell transplantation 29, 0963689720968749, 2020 | 29 | 2020 |
| Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations G Simonetti, C Mengucci, A Padella, E Fonzi, G Picone, C Delpino, ... Leukemia 35 (10), 2813-2826, 2021 | 19 | 2021 |
| Estrogen and androgen receptor inhibitors: unexpected allies in the fight against COVID-19 S Bravaccini, E Fonzi, M Tebaldi, D Angeli, G Martinelli, F Nicolini, ... Cell Transplantation 30, 0963689721991477, 2021 | 19 | 2021 |
| Multigene panel testing increases the number of loci associated with gastric cancer predisposition G Tedaldi, F Pirini, M Tebaldi, V Zampiga, I Cangini, R Danesi, ... Cancers 11 (9), 1340, 2019 | 18 | 2019 |
| First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer G Tedaldi, R Danesi, V Zampiga, M Tebaldi, L Bedei, W Zoli, D Amadori, ... BMC cancer 14, 1-5, 2014 | 18 | 2014 |
| Lineage‐specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture C Liverani, A De Vita, C Spadazzi, G Miserocchi, C Cocchi, ... Molecular Oncology 16 (4), 921-939, 2022 | 17 | 2022 |
| Male breast cancer: results of the application of multigene panel testing to an Italian cohort of patients G Tedaldi, M Tebaldi, V Zampiga, I Cangini, F Pirini, E Ferracci, R Danesi, ... Diagnostics 10 (5), 269, 2020 | 14 | 2020 |
| Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman L Bonanno, F Calabrese, G Nardo, D Calistri, M Tebaldi, G Tedaldi, ... Lung Cancer 96, 52-55, 2016 | 10 | 2016 |
| Dissecting molecular heterogeneity of circulating tumor cells (CTCs) from metastatic breast cancer patients through copy number aberration (CNA) and single nucleotide variant … T Rossi, D Angeli, M Tebaldi, P Fici, E Rossi, A Rocca, M Palleschi, ... Cancers 14 (16), 3925, 2022 | 9 | 2022 |
| Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer. Oncotarget. 2017; 8 (29): 47064 G Tedaldi, M Tebaldi, V Zampiga, R Danesi, V Arcangeli, M Ravegnani | 6 | |
| Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic … M Bocchini, M Tazzari, S Ravaioli, F Piccinini, F Foca, M Tebaldi, ... Frontiers in Oncology 13, 1136331, 2023 | 5 | 2023 |
| Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing V Zampiga, R Danesi, G Tedaldi, M Tebaldi, I Cangini, F Pirini, C Pittureri, ... The International Journal of Biological Markers 31 (4), 461-465, 2016 | 5 | 2016 |
| Case report: Analysis of circulating tumor cells in a triple negative spindle-cell metaplastic breast cancer patient T Rossi, M Palleschi, D Angeli, M Tebaldi, G Martinelli, I Vannini, ... Frontiers in Medicine 8, 689895, 2021 | 4 | 2021 |
| Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area V Zampiga, I Cangini, E Bandini, I Azzali, M Ravegnani, A Ravaioli, ... Cancers 15 (7), 2132, 2023 | 2 | 2023 |
